Merlin Jan Klußmann

Mr. Merlin Jan Klußmann

University of Cologne, Department of Chemistry, Institute of Biochemistry
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DLDirk Lindenblatt
Dirk Lindenblatt
VAVioletta Applegate
Violetta Applegate
ANAnna Nickelsen
Anna Nickelsen
Merlin Jan KlußmannMerlin Jan Klußmann
Merlin Jan Klußmann
Ines NeundorfInes Neundorf
Ines Neundorf
Karsten NiefindKarsten Niefind
Karsten Niefind

13 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
FGFélix Gayraud
Félix Gayraud
Merlin Jan KlußmannMerlin Jan Klußmann
Merlin Jan Klußmann
Ines NeundorfInes Neundorf
Ines Neundorf
This review summarizes recent developments in conjugation techniques for the synthesis of cell-penetrating peptide (CPP)–drug conjugates targeting cancer cells. We will focus on small organic molecules as well as metal complexes that were used as cytostatic payloads. Moreover, two principle ways of coupling chemistry will be discussed direct conjugation as well as the use of bifunctional linkers. While direct conjugation of the drug to the CPP is still popular, the use of bifunctional linkers seems to gain increasing attention as it offers more advantages related to the linker chemistry. Thus, three main categories of linkers will be highlighted, forming either disulfide acid-sensitive or stimuli-sensitive bonds. All techniques will be thoroughly discussed by their pros and cons with the aim to help the reader in the choice of the optimal conjugation technique that might be used for the synthesis of a given CPP–drug conjugate